Strikingly, the combined deletion of Vdac2 and Bak also accelerated AML development when compared with deletion of Bak alone (Fig. 6), affirming that VDAC2 is a key mediator of BAX activation in the context of oncogenic stress. Here, VDAC2 is linked to acute myeloid leukemia.